Trial
NCT03325101
Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Stage III Cutaneous Melanoma AJCC v7
Intervention
Cryosurgery
Why stopped
poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-12